| Literature DB >> 33149434 |
Chandramohan Ravivarman1, Athikesavan Jeyasenthil2, Ranganathan Ajay3, Nasir Nilofernisha4, Radhakrishnan Karthikeyan5, Durairaj Rajkumar6.
Abstract
BACKGROUND: Eugenol released from zinc oxide eugenol (ZOE)-based sealants may cause irritation to the periapical tissues and has cytotoxic potential. Ozone therapy has numerous clinical applications with humans because of its bactericidal action, detoxifying effect, stimulation of angiogenesis, and wound-healing capacity. Therefore ozone can be incorporated in ZOE sealer to exploit these properties.Entities:
Keywords: Cytotoxicity; eugenol; ozone; sealer; zinc oxide
Year: 2020 PMID: 33149434 PMCID: PMC7595563 DOI: 10.4103/jpbs.JPBS_21_20
Source DB: PubMed Journal: J Pharm Bioallied Sci ISSN: 0975-7406
Figure 1Zinc oxide powder, eugenol, glass slab, stainless steel spatula, and stainless steel rings
Figure 2Ozonator machine (output: 400 mg/h; Ozonator; Eltech Ozone, Mumbai, India)
Mean and standard deviation of pH values
| Time of testing | Group | Mean | Standard deviation | |
|---|---|---|---|---|
| Freshly mixed | I | 6.5667 | 0.20817 | |
| II | 7.5667 | 0.35119 | ||
| After 12 h | I | 6.1000 | 0.17321 | |
| II | 6.7667 | 0.15275 | ||
| After 24 h | I | 5.7667 | 0.30551 | |
| II | 6.2667 | 0.32146 |
Mean and standard deviation of cell viability %
| Group | Mean | Standard deviation | |
|---|---|---|---|
| I | 52.6000 | 1.00167 | |
| II | 68.4333 | 1.15326 |